DMA® Neurodegenerative Diseases

DMA® permits the investigation of the brain structures’ metabolic processes. The assessment considers both the systems: the limbic (e.g. hippocampus, amygdala, corpus callosum, epiphysis, hypothalamus), and the cortical (motor, frontal, prefrontal, temporal, parietal occipital, nuclei of the base).

Doctors can evaluate the presence and the progress of neurodegenerations such as beta-amyloid plaque, axonic demyelination, and the formation and progression of neurofibrillary tangles.

It is possible to observe the progression of damage from hypo-oxygenation or low blood flow, inflammation and infections of the brain and cerebellum, and electrical anomalies of the spinal column helpful in understanding diseases such as Multiple Sclerosis Sclerosis Lateral Amyotrophic, Parkinson’s disease, and many others.